Novel Biomarkers of Non-IgE Immediate Hypersensitivity Drug Reactions | MicrobiomeTrials← Back to trialsNCT07605806
Novel Biomarkers of Non-IgE Immediate Hypersensitivity Drug Reactions
RecruitingPHASE1, PHASE2INTERVENTIONAL
Trial Details
Start: 2026-05-21Est. Completion: 2027-05-30
Enrollment target: 25 participants Locations- Johns Hopkins University School of Medicine, Baltimore, Maryland, United States
Other microbiome trials you might be interested in
Vasomotor Symptoms Associated With MenopauseHealthy Volunteers
The purpose of this study is to evaluate the effects of single and multiple doses of ABCL635 administered by subcutaneou…
Calgary, CanadaEst. completion Feb 2027
Primary ImmunodeficiencyDOCK8Virus Susceptibility
Background:
* National Institutes of Health (NIH) researchers have been studying immune cells (white blood cells) to be…
Bethesda, United States